However, since the gene targeting of CtIP is not confirmed [43] and the mammary tumors developed in p53-deficient mice are typical BLBCs with EMT features [44], it remains elusive whether CtIP plays a role in regulating luminal to basal or mesenchymal differentiation in normal or cancerous mammary cells. The gene discussed is TP53; the disease is breast cancer.